The University of Maryland Baltimore Center for Pain Studies (hereafter referred to as the "Center") is dedicated to advancing the science of cancer treatment-related pain management through basic, translational and clinical studies. To achieve our objectives, we will enhance our campus research infrastructure to increase the quantity and quality of interdisciplinary biobehavioral studies in pain. Our outstanding group of interdisciplinary researchers from several schools and programs on campus, including Nursing (SON), Medicine (SOM), Dentistry (SOD) and the University of Maryland Medical Center Marlene and Stewart Greenebaum Cancer Center (UMMCGCC), has been working together for the past year to study the development and persistence of cancer treatment-related pain. We have started, on our campus, to build an infrastructure to support both basic and clinical studies, including behavioral testing of pain in animal models, quantitative sensory testing (QST) in human subjects, a repository of clinical self-report instruments to examine the pain experience including related psychosocial variables, and a genetics core to conduct unbiased, whole genome assays in both animal models and human subjects. This Center funding will enable us to formalize, enhance, and enact plans to sustain our Center on campus.

National Institute of Health (NIH)
National Institute of Nursing Research (NINR)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZNR1-REV-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Maryland Baltimore
United States
Zip Code
Griffith, Kathleen A; Couture, Darren J; Zhu, Shijun et al. (2014) Evaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations. Support Care Cancer 22:1161-9
Bao, Ting; Goloubeva, Olga; Pelser, Colleen et al. (2014) A pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myeloma. Integr Cancer Ther 13:396-404
Griffith, Kathleen A; Dorsey, Susan G; Renn, Cynthia L et al. (2014) Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study. J Peripher Nerv Syst 19:127-35
Dorsey, Susan G; Schiffman, Rachel; Redeker, Nancy S et al. (2014) National Institute of Nursing Research Centers of Excellence: a logic model for sustainability, leveraging resources, and collaboration to accelerate cross-disciplinary science. Nurs Outlook 62:384-93
Alberti, P; Rossi, E; Cornblath, D R et al. (2014) Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin. Ann Oncol 25:257-64
Carozzi, Valentina A; Renn, Cynthia L; Bardini, Michela et al. (2013) Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse. PLoS One 8:e72995
Cavaletti, G; Cornblath, D R; Merkies, I S J et al. (2013) The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Ann Oncol 24:454-62
Wang, Xiao-Min; Lehky, Tanya J; Brell, Joanna M et al. (2012) Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. Cytokine 59:3-9
Mei, Y-P; Liao, J-P; Shen, J et al. (2012) Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene 31:2794-804
Ayala, Victor I; Teijaro, John R; Farber, Donna L et al. (2011) Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity. PLoS One 6:e19016

Showing the most recent 10 out of 12 publications